Loading company…
Won 2 federal SBIR/STTR research awards from HHS and other federal agencies.
STINGRAY THERAPEUTICS INC has been awarded 2 US Small Business Innovation Research (SBIR/STTR) contracts totalling $3,457,194 between 2022 and 2025. These are non-dilutive federal research grants, not equity financing. The company is based in HOUSTON, Texas.
No investors recorded yet for STINGRAY THERAPEUTICS INC.
Add an investorSTINGRAY THERAPEUTICS INC has no recorded acquisitions.
Add an acquisitionStill private — no exit on record.
Record an exitNo diversity signals recorded yet for STINGRAY THERAPEUTICS INC.
Add diversity data